Blood-based proteomic biomarkers for predicting response to immunotherapy in non-small cell lung cancer

被引：0
|
作者：
Shaked, Y. [1 ]
Kamer, I. [2 ]
Harel, M. [3 ]
Lahav, C. [3 ]
Jacob, E. [3 ]
Issler, E. [3 ]
Dicker, A. P. [4 ]
Bar, H. [5 ]
Sharon, O. [3 ]
Bar, J. [2 ]
机构：
[1] Technion Israel Inst Technol, Fac Med, Haifa, Israel
[2] Chaim Sheba Med Ctr, Inst Oncol, Ramat Gan, Israel
[3] OncoHost, Binyamina, Israel
[4] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[5] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1628
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1314P
引用
收藏
页码：S849 / S849
页数：1
相关论文
共 50 条
  • [1] Emerging Blood-Based Biomarkers for Predicting Response to Checkpoint Immunotherapy in Non-Small-Cell Lung Cancer
    Li, Shumin
    Zhang, Chengyan
    Pang, Guanchao
    Wang, Pingli
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [2] Comprehensive analysis of blood-based biomarkers for predicting immunotherapy benefits in patients with advanced non-small cell lung cancer
    Park, Cheol-Kyu
    Oh, Hyung-Joo
    Kim, Min-Seok
    Koh, Bo-Gun
    Cho, Hyun-Ju
    Kim, Young-Chul
    Yang, Hyung-Jeong
    Lee, Ji-Young
    Chun, Sung-Min
    Oh, In-Jae
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (05) : 2103 - +
  • [3] Blood-Based Biomarkers for Predicting Immunotherapy Benefit in Lung Cancer
    Camidge, D. Ross
    Schenk, Erin L.
    [J]. CELL, 2020, 183 (02) : 303 - 304
  • [4] Clinical significance of blood-based miRNAs as biomarkers of non-small cell lung cancer
    Li, Lin
    Sun, Yu
    Feng, Min
    Wang, Liang
    Liu, Jing
    [J]. ONCOLOGY LETTERS, 2018, 15 (06) : 8915 - 8925
  • [5] Blood-based biomarkers for monitoring antiangiogenic therapy in non-small cell lung cancer
    Analia Rodríguez Garzotto
    C. Vanesa Díaz-García
    Alba Agudo-López
    Elena Prieto García
    Santiago Ponce
    José A. López-Martín
    Luis Paz-Ares
    Lara Iglesias
    M. Teresa Agulló-Ortuño
    [J]. Medical Oncology, 2016, 33
  • [6] Blood-based biomarkers for monitoring antiangiogenic therapy in non-small cell lung cancer
    Rodriguez Garzotto, Analia
    Vanesa Diaz-Garcia, C.
    Agudo-Lopez, Alba
    Prieto Garcia, Elena
    Ponce, Santiago
    Lopez-Martin, Jose A.
    Paz-Ares, Luis
    Iglesias, Lara
    Teresa Agullo-Ortuno, M.
    [J]. MEDICAL ONCOLOGY, 2016, 33 (10)
  • [7] Longitudinal blood-based proteomic testing in advanced non-small cell lung cancer.
    Schaefer, Eric
    Mitchell, R. Brian
    Boyd, Jason
    Orsini, James
    Nagajothi, Nagaprasad
    Bidyasar, Savita
    Khalil, Mazen
    Haut, Mitchell
    Page, Ray
    Huang, Kan
    Dubay, John W.
    Akerley, Wallace
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [8] Predicting response to immunotherapy in advanced non-small cell lung cancer
    Rebordao Pires, M.
    Amorim Costa, C.
    Cunha Pereira, T.
    Monteiro, J. C.
    Domingues, I.
    Caetano, A. C.
    Meira Garcia, A. R.
    Jesus, E.
    Sousa, G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S768 - S768
  • [9] Biomarkers of immunotherapy for non-small cell lung cancer
    Shirasawa, Masayuki
    Yoshida, Tatsuya
    Ohe, Yuichiro
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (01) : 13 - 22
  • [10] Biomarkers of immunotherapy in non-small cell lung cancer
    Wang, Lingling
    Hu, Yue
    Wang, Shengchao
    Shen, Jiali
    Wang, Xiaochen
    [J]. ONCOLOGY LETTERS, 2020, 20 (05)
12345